Department of Medicine, Queen Mary Hospital

Hong Kong 999077

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Neoplasms, PD-L1 Positive, Rheumatoid Arthritis, Triple Negative Breast Cancer

Studies at this site

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer — Completed